TODAY

2024. 07. 27.

D-40

Scientific Program

  • 15:00-16:30

    Committee Session 1

    will be updated.
    15:00-15:30

    15:30-16:00

    16:00-16:30

  • 16:30-18:00

    Committee Session 2

    will be updated.
    16:30-17:00

    17:00-17:30

    17:30-18:00

  • 18:00-18:10

    Break

  • 18:10-18:40

    Satellite Symposium 1

    Chairperson : Suk Chon (Kyung Hee University, Korea)

    will be updated.
    18:10-18:40 Insulin Therapy Optimization: Unlocking the Potential for Better Diabetes Treatment

    Eun Young Lee

    (The Catholic University of Korea, Korea)
  • 18:40-19:10

    Satellite Symposium 2

    Chairperson : Changhyun Lee (Seoul Happiness Clinic of Internal Medicine, Korea)

    will be updated.
    18:40-19:10

    Se Hee Min

    (University of Ulsan, Korea)
  • 15:00-16:30

    Joint Symposium KSSO-JKT (Clinical)

    Chairpersons : Cheol-Young Park (Sungkyunkwan University, Korea),
    Wen-Yuan Lin (China Medical University, Taiwan)

    will be updated.
    15:00-15:30 Noninvasive Approaches to Monitor Liver Fibrosis in Metabolic-Associated Steatotic Liver Disease

    Hye Won Lee

    (Yonsei University, Korea)
    15:30-16:00 Effects of Exercise Intervention in Subjects with Steatotic Liver Disease

    Chun-Jen Liu

    (National Taiwan University, Taiwan)
    16:00-16:30 MASLD and Cardio-Renal-Metabolic Syndrome

    Masato Furuhashi

    (Sapporo Medical University, Japan)
  • 16:30-18:00

    Joint Symposium KSSO-JKT (Basic)

    Chairpersons : Ki Woo Kim (Yonsei University, Korea),
    Jun Wada (Okayama University, Japan)

    will be updated.
    16:30-17:00 Molecular Pathophysiology Underlying MASH Complicated by Diabetes

    Hisanori Goto

    (Kanazawa University, Japan)
    17:00-17:30 Effects of Exercise Intervention in Obese Mice with Steatotic Liver Disease

    Chia-Wen Lu

    (National Taiwan University, Taiwan)
    17:30-18:00 Therapeutic Approaches for Non-Alcoholic Steatohepatitis Utilizing Diverse Metabolites

    Eun Hee Koh

    (University of Ulsan, Korea)
  • 18:00-18:10

    Break

  • 18:10-18:40

    Satellite Symposium 3

    Chairperson : Bom Taeck Kim (Ajou University, Korea)

    will be updated.
    18:10-18:40

    Jung Hwan Park

    (Hanyang University, Korea)
  • 18:40-19:10

    Special Session for Publication

    Chairperson : You-Cheol Hwang (Kyung Hee University, Korea)

    will be updated.
    18:40-19:10

    Claire Greenhill

    (Nature Reviews Endocrinology, UK)
  • 15:00-16:10

    Best Articles in JOMES

    Chairpersons : You-Cheol Hwang (Kyung Hee University, Korea) ,
    Yong-Ho Lee (Yonsei University, Korea)

    15:00-15:15 2023 Obesity Fact Sheet: Prevalence of Obesity and Abdominal Obesity in Adults, Adolescents, and Children in Korea from 2012 to 2021

    Su-Min Jeong

    (Seoul National University, Korea)
    15:15-15:30 Association between Sleep Duration and Metabolic Disorders among Filipino Immigrant Women: The Filipino Women’s Diet and Health Study (FiLWHEL)

    Jung Eun Lee

    (Seoul National University, Korea)
    15:30-15:45 Effects of Cardiorespiratory Fitness on Cardiovascular Disease Risk Factors and Telomere Length by Age and Obesity

    Yun-A Shin

    (Dankook University, Korea)
    15:45-16:00 Temporal Trends of the Prevalence of Abdominal Obesity and Metabolic Syndrome in Korean Children and Adolescents between 2007 and 2020

    Jieun Lee

    (Inje University, Korea)
    16:00-16:10 Award Ceremony

  • 16:20-17:50

    Joint Symposium KSSO-KSoLA-KDA

    Chairpersons : Cheol-Young Park (Sungkyunkwan University, Korea) ,
    Woo Je Lee (University of Ulsan, Korea)

    will be updated.
    16:20-16:45 Interim Report for 2024 Update of Clinical Practice Guidelines for Obesity by the Korean Society for the Study of Obesity

    Seo Young Kang

    (Eulji University, Korea)
    16:45-17:10

    Dong-Hyuk Cho

    (Korea University, Korea)
    17:10-17:35 The Impact of Anti-Obesity Agents on Glucose Metabolism

    Jae-Han Jeon

    (Kyungpook National University, Korea)
    17:35-17:50 Panel Discussion

    Jong Chan Youn

    (The Catholic University of Korea, Korea),

    Jun Sung Moon

    (Yeungnam University, Korea),

    Eun Young Lee

    (The Catholic University of Korea, Korea)
  • 18:00-18:10

    Break

  • 19:00-21:00

    Textbook Launch Ceremony & Welcome Reception

  • 07:30-08:20

    Breakfast Symposium 1

    Chairperson : Kiyoung Lee (Gachon University, Korea)

    will be updated.
    07:30-08:20 The Ideal Combination therapy for T2D Including Original Dapagliflozin

    Jae-Han Jeon

    (Kyungbook National University, Korea)
  • 08:20-08:30

    Break

  • 08:30-09:10

    Keynote Lecture 1

    Chairperson : Min-Seon Kim (University of Ulsan, Korea)

    Organizer : Ki Woo Kim (Yonsei University, College of Dentistry, Korea)

    • In this session, Dr. Elmquist, Dean of Research at UT-Southwestern Medical Center and Director of the Center for Hypothalamic Research, will introduce a new platform for identifying key factors in obesity and metabolic regulation through the hypothalamus. He will explain the identified factors and present the latest research on how these factors influence whole-body homeostasis. This presentation will provide crucial insights into the mechanisms of hypothalamic function and the regulation of obesity and metabolic disorders, greatly benefiting conference attendees.
    • • References
      1. Coordination of metabolism, arousal, and reward by orexin/hypocretin neurons
      2. Leptin and brain-adipose crosstalks
    08:30-09:00 SF-1 Targets in the Hypothalamus: Novel Pathways Regulating Energy Balance and Metabolism

    Joel K. Elmquist

    (UT Southwestern Medical Center, USA)
    09:00-09:10 Q&A
  • 09:10-09:20

    Break

  • 09:20-10:50

    Symposium 1 : Precision Medicine for Obesity and Diabetes

    Chairpersons : Leonie Kaye Heilbronn (University of Adelaide, Australia),
    Soon-Jib Yoo (The Catholic University of Korea, Korea)

    Organizer: Seung-Hwan Lee (The Catholic University of Korea, Korea), Jae Hyun Bae (Korea University, Korea)

    • This session will explore the role, current status, and future prospects of precision medicine in managing obesity and diabetes. Jean-Pierre Després from VITAM – Research Centre on Sustainable Health, Canada, will discuss obesity phenotypes and their implications. Yoon Jung Park from Ewha Womans University, Korea, will cover weight management strategies using nutrigenomics. Joonyub Lee from The Catholic University of Korea will present precision diabetes care through integrative life-log data and digital twin technology.
    • • References
      1. Piché ME, Tchernof A, Després JP. Obesity Phenotypes, Diabetes, and Cardiovascular Diseases. Circ Res. 2020;126(11):1477-1500
      2. Shon J, Han Y, Song S, Kwon SY, Na K, Lindroth AM, Park YJ. Anti-obesity effect of butyrate links to modulation of gut microbiome and epigenetic regulation of muscular circadian clock. J Nutr Biochem. 2024;127:109590
      3. Lee J, Yu J, Yoon KH. Opening the Precision Diabetes Care through Digital Healthcare. Diabetes Metab J. 2023;47(3):307-314
    09:20-09:45 Obesity Phenotypes and Precision Medicine

    Jean-Pierre Després

    (VITAM – Research Centre on Sustainable Health, Canada)
    09:45-10:10 Nutrigenomics of Obesity and Weight Management

    Yoon Jung Park

    (Ewha Womans University, Korea)
    10:10-10:35 Precision Diabetes Care through Integrative Life-Log Data

    Joonyub Lee

    (The Catholic University of Korea, Korea)
    10:35-10:50 Panel Discussion

    Tae Nyun Kim

    (Inje University, Korea),

    Jae Hyun Bae

    (Korea University, Korea)
  • 10:50-11:00

    Break

  • 11:00-11:10

    Opening Address

  • 11:10-11:50

    Plenary Lecture 1

    Chairperson : Jeong Taek Woo (Kyung Hee University, Korea)

    Organizer: Soo Lim (Seoul National University, Republic of Korea)

    • Matthias Blüher is Head of the Obesity Outpatient Clinic for Adults at the University of Leipzig Department of Medicine in Leipzig, Germany. He is Professor of Molecular Endocrinology, with board certifications in Internal Medicine, Endocrinology and Diabetology. From 2006 to 2012, Professor Blüher served as Head of the Clinical Research Group ‘Atherobesity,’ and since 2013, he has been Speaker of the Collaborative Research Center on obesity mechanisms.
    • Professor Blüher has won several awards, including the Obesity Research Award of the German Society for the Study of Obesity, the Ferdinand-Bertram-Prize of the German Diabetes Association, and the Rising Star Lecture at the 44th European Association for the Study of Diabetes (EASD) meeting. More recently, he received the Hans Christian Hagedorn Award from the German Diabetes Association in 2011 and the Minkowski Award from the EASD in 2015.
    • • References
      1. Blüher M, Aras M, Aronne LJ, Batterham RL, Giorgino F, Ji L, Pietiläinen KH, Schnell O, Tonchevska E, Wilding JPH. New insights into the treatment of obesity. Diabetes Obes Metab. 2023 Apr 13. doi: 10.1111/dom.15077.
      2. Blüher M. Metabolically Healthy Obesity. Endocr Rev. 2020 May 1;41(3):bnaa004.
    11:10-11:40 GLP-1 Based Therapy of Obesity

    Michael A. Nauck

    (Ruhr-University Bochum, Germany)
    11:40-11:50 Q&A
  • 11:50-12:00

    Break

  • 12:00-13:00

    Luncheon Symposium 1

    Chairperson : Hyung Joon Yoo (CM Hospital, Korea)

    will be updated.
    12:00-13:00 Optimal Combination Therapy for Diabetes Management

    Bukyung Kim

    (Kosin University, Korea)
  • 13:00-13:40

    Special Scientific Session 1

    Organizer: Soo Lim (Seoul National University, Republic of Korea)

    • Matthias Blüher is Head of the Obesity Outpatient Clinic for Adults at the University of Leipzig Department of Medicine in Leipzig, Germany. He is Professor of Molecular Endocrinology, with board certifications in Internal Medicine, Endocrinology and Diabetology. From 2006 to 2012, Professor Blüher served as Head of the Clinical Research Group ‘Atherobesity,’ and since 2013, he has been Speaker of the Collaborative Research Center on obesity mechanisms.
    • Professor Blüher has won several awards, including the Obesity Research Award of the German Society for the Study of Obesity, the Ferdinand-Bertram-Prize of the German Diabetes Association, and the Rising Star Lecture at the 44th European Association for the Study of Diabetes (EASD) meeting. More recently, he received the Hans Christian Hagedorn Award from the German Diabetes Association in 2011 and the Minkowski Award from the EASD in 2015.
    • • References
      1. Blüher M, Aras M, Aronne LJ, Batterham RL, Giorgino F, Ji L, Pietiläinen KH, Schnell O, Tonchevska E, Wilding JPH. New insights into the treatment of obesity. Diabetes Obes Metab. 2023 Apr 13. doi: 10.1111/dom.15077.
      2. Blüher M. Metabolically Healthy Obesity. Endocr Rev. 2020 May 1;41(3):bnaa004.
    13:00-13:30 Nutrients-Stimulated Hormone-Based Pharmacotherapy for the Treatment of Obesity: Sparks from the Pipeline!

    Ania Jastreboff

    (Yale University, USA)
    11:40-11:50 Q&A
  • 14:00-15:30

    Symposium 5 : Current Perspectives on Health Inequity in Obesity

    Chairpersons : Young Seol Kim (Kyung Hee University, Korea),
    Kyung-Hee Park (Hallym University, Korea)

    Organizer: Kyung Hee Park (Hallym University, Republic of Korea), Jin-Wook Kim (Hippocrata Clinic), Yoon Jeong Cho (Daegu Catholic University, Republic of Korea)

    • The development of new drugs for treating obesity is ongoing, and more potent medications are being introduced. Among them, semaglutide and tirzepatide will soon be available in Korea, and their efficacy has been proven based on various clinical trials. In Symposium 5, we will discuss the efficacy of semaglutide and tirzepatide, as well as expectations and side effects associated with their use. In line with this, we will explore the safety and status of drug abuse when using anti-obesity drugs, which should be considered as important as their efficacy. This symposium will provide an opportunity for us to collectively contemplate the direction for optimal treatment in this field.
    • • References
      1. J Obes Metab Syndr. 2023 Jun 30; 32(2): 121–129. Diagnosis of Obesity: 2022 Update of Clinical Practice Guidelines for Obesity by the Korean Society for the Study of Obesity
      2. Lancet Diabetes Endocrinol 2022; 10: 193–206. Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial
      3. Diabetes Obes Metab. 2023 Apr;25(4):1056-1067. Safety and efficacy analyses across age and body mass index subgroups in East Asian participants with type 2 diabetes in the phase 3 tirzepatide studies (SURPASS programme)
      4. Diabetes Obes Metab.2021;23:1232–1241.Cardiovascular safety of evogliptin in patients with type 2 diabetes: A nationwide cohort study.
    14:00-14:25 Obesity Related Health Disparities - A Specific Case of Low- and Middle-Income Countries

    Monika Chaudhary

    (Johns Hopkins University, USA)
    14:25-14:50 The Food Insecurity - Obesity Paradox and Strategies to Address Food Insecurity

    Seul Ki Choi

    (University of Seoul, Korea)
    14:50-15:15 Managing Weight in Urban Neighborhoods: Qualitative Case Studies

    Seunghyun Yoo

    (Seoul National University, Korea)
    15:15-15:30 Panel Discussion

    Kyunghee Jung-Choi

    (Ewha Womans University, Korea),

    Sang Min Park

    (Seoul National University, Korea)
  • 15:30-15:40

    Break

  • 15:40-16:20

    Plenary Lecture 2

    Chairperson : Kee-Hyoung Lee (Korea University, Korea)

    Organizer : Yong Hee Hong (Soonchunhyang University, Korea)

    • Prof. Silva Arslanian is one of the global leaders in research on pediatric obesity and type 2 diabetes. She is a pediatric endocrinologist and a scientific director of the Center for Pediatric Research in Obesity and Metabolism at the University of Pittsburgh. She is the recipient of several prestigious awards, the latest being the 2023 American Diabetes Association Outstanding Achievement Award. In this keynote lecture, she will introduce new pharmacotherapeutic modalities for youth-onset type 2 diabetes, which has recently been on the rise globally as well as in Korea.
    15:40-16:10 Management of Youth Type 2 Diabetes: New Pharmacotherapeutic Modalities

    Silva Arslanian

    (University of Pittsburgh, USA)
    16:10-16:20 Q&A
  • 16:20-16:30

    Break

  • 16:30-18:00

    Symposium 9 : Obesity and Cardiovascular Health

    Chairpersons : Yoon-Sok Chung (Ajou University, Korea),
    Do Thi Ngoc Diep (Vietnam Nutrition Association, Vietnam)

    Organizer: Yun-Hee Lee (Seoul National University, Republic of Korea)

    • The topic of this session is “Obesity in special conditions”. Beyond recognizing obesity as the same disease condition, we would like to have time to look at cases with various accompanying diseases. The first speaker, Dicky L. Tahapary, will discuss the diagnosis and treatment of obese patients with diabetes. The second speaker, Wen-Yuan Lin, will introduce studies related to obesity with sarcopenia. The last speaker, Professor Tae Nyun Kim, will discuss the new concept of osteoporosis-sarcopenic obesity.
    16:30-16:55 Reconsidering the Role of Mitochondria in Nutrient Sensing

    Richard Kibbey

    (Yale University, USA)
    16:55-17:20 Bariatric Surgery in Patients with Advanced Heart Failure

    Kyung-Hee Kim

    (Incheon Sejong Hospital, Korea)
    17:20-17:45 Body Composition and Its Associations with Disease Risk: Measures, Assessment Techniques, and Future Directions

    Jonathan Bennett

    (University of Hawaii Cancer Center, USA)
    17:45-18:00 Panel Discussion
  • 18:05-18:40

    EASO Presidential Lecture

    Chairperson : Sung Rae Kim (The Catholic University of Korea, Korea)

    Organizer : Jang Won Son (The Catholic University of Korea, Republic of Korea)

    • Professor Thiruma V. Arumugam, a distinguished researcher in the fields of physiology and pharmacology at La Trobe University, Australia, is pushing the boundaries of neuroscience and metabolism. In his upcoming lecture, he will discuss how his work on intermittent metabolic switching has enhanced our comprehension of its effect on brain health, paving the way for potential therapeutic interventions.
    • His recent publication in Theranostics, titled "Time-restricted feeding modulates the DNA methylation landscape, attenuates hallmark neuropathology and cognitive impairment in a mouse model of vascular dementia," has presented novel insights into the therapeutic potential of intermittent metabolic switching, offering promising strategies for managing and potentially reversing cognitive impairment in dementia.
    • Further expanding our understanding, Professor Arumugam's article in Cell Metabolism, "Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States," continues to revolutionize our perspective on the role of metabolism in brain aging.
    18:05-18:35 Management of Obesity in Older Adults

    Volkan Yumuk

    (Istanbul University-Cerrahpaşa, Turkey)
    09:00-09:10 Q&A
  • 07:30-08:20

    Breakfast Symposium 2

    Chairperson : Chul Sik Kim (Yonsei University, Korea)

    will be updated.
    07:30-08:20 Efficacy and Safety of Naltrexone-Bupropion in Korean Adults with Obesity: Post-Marketing Surveillance Study

    Young Sang Lyu

    (Chosun University, Korea)
  • 08:20-08:30

    Break

  • 08:30-09:10

    Keynote Lecture 1

    Chairperson : Min-Seon Kim (University of Ulsan, Korea)

    Organizer : Ki Woo Kim (Yonsei University, College of Dentistry, Korea)

    • In this session, Dr. Elmquist, Dean of Research at UT-Southwestern Medical Center and Director of the Center for Hypothalamic Research, will introduce a new platform for identifying key factors in obesity and metabolic regulation through the hypothalamus. He will explain the identified factors and present the latest research on how these factors influence whole-body homeostasis. This presentation will provide crucial insights into the mechanisms of hypothalamic function and the regulation of obesity and metabolic disorders, greatly benefiting conference attendees.
    • • References
      1. Coordination of metabolism, arousal, and reward by orexin/hypocretin neurons
      2. Leptin and brain-adipose crosstalks
    08:30-09:00 SF-1 Targets in the Hypothalamus: Novel Pathways Regulating Energy Balance and Metabolism

    Joel K. Elmquist

    (UT Southwestern Medical Center, USA)
    09:00-09:10 Q&A
  • 09:10-09:20

    Break

  • 09:20-10:50

    Symposium 2 : Gut, Brain, and Obesity

    Chairpersons : Wen-Yuan Lin (China Medical University, Taiwan),
    Kae Won Cho (Soonchunhyang University, Korea)

    Organizer : Jang Won Son (The Catholic University of Korea, Korea), Kyung Ae Lee (Jeonbuk National University, Korea)

    • This insightful symposium will feature groundbreaking research on the intricate interactions between the gut microbiota, peripheral organs, and the central nervous system in the context of obesity and metabolic regulation. Prof. Chih-Yen Chen from National Yang Ming Chiao Tung University in Taiwan, will discuss on gut hormone, brain, and obesity, Prof. Teppei Fujikawa from UT Southwestern Medical Center in the USA, will present his research on decoding VMH regulation of food intake in adults, and last but not least, Prof. Ki Woo Kim from Yonsei University in Korea, will explore how a microbiota-derived short chain fatty acid targets the hypothalamus and regulates energy balance.
    09:20-09:45 Gut Hormone, Brain, and Obesity

    Chih-Yen Chen

    (National Yang Ming Chiao Tung University, Taiwan)
    09:45-10:10 Decoding VMH Regulation of Food Intake in Adults

    Teppei Fujikawa

    (UT Southwestern Medical Center, USA)
    10:10-10:35 A Microbiota-Derived Short Chain Fatty Acid Targets the Hypothalamus and Regulates Energy Balance

    Ki Woo Kim

    (Yonsei University, Korea)
    10:35-10:50 Panel Discussion

    Obin Kwon

    (Seoul National University, Korea),

    Jaemin Lee

    (DGIST, Korea)
  • 10:50-11:00

    Break

  • 11:00-11:10

    Opening Address

  • 11:10-11:50

    Plenary Lecture 1

    Chairperson : Jeong Taek Woo (Kyung Hee University, Korea)

    Organizer: Soo Lim (Seoul National University, Republic of Korea)

    • Matthias Blüher is Head of the Obesity Outpatient Clinic for Adults at the University of Leipzig Department of Medicine in Leipzig, Germany. He is Professor of Molecular Endocrinology, with board certifications in Internal Medicine, Endocrinology and Diabetology. From 2006 to 2012, Professor Blüher served as Head of the Clinical Research Group ‘Atherobesity,’ and since 2013, he has been Speaker of the Collaborative Research Center on obesity mechanisms.
    • Professor Blüher has won several awards, including the Obesity Research Award of the German Society for the Study of Obesity, the Ferdinand-Bertram-Prize of the German Diabetes Association, and the Rising Star Lecture at the 44th European Association for the Study of Diabetes (EASD) meeting. More recently, he received the Hans Christian Hagedorn Award from the German Diabetes Association in 2011 and the Minkowski Award from the EASD in 2015.
    • • References
      1. Blüher M, Aras M, Aronne LJ, Batterham RL, Giorgino F, Ji L, Pietiläinen KH, Schnell O, Tonchevska E, Wilding JPH. New insights into the treatment of obesity. Diabetes Obes Metab. 2023 Apr 13. doi: 10.1111/dom.15077.
      2. Blüher M. Metabolically Healthy Obesity. Endocr Rev. 2020 May 1;41(3):bnaa004.
    11:10-11:40 GLP-1 Based Therapy of Obesity

    Michael A. Nauck

    (Ruhr-University Bochum, Germany)
    11:40-11:50 Q&A
  • 11:50-12:00

    Break

  • 12:00-13:00

    Luncheon Symposium 2

    Chairperson : Gyeong-Su Kim (The Catholic University of Korea, Korea)

    will be updated.
    12:00-13:00 DPP-IV Inhibitor and SGLT2 Inhibitor Combination Therapy for the Treatment of T2DM

    Joonyub Lee

    (The Catholic University of Korea, Korea)
  • 13:00-13:40

    Special Scientific Session 1

    Organizer: Soo Lim (Seoul National University, Republic of Korea)

    • Matthias Blüher is Head of the Obesity Outpatient Clinic for Adults at the University of Leipzig Department of Medicine in Leipzig, Germany. He is Professor of Molecular Endocrinology, with board certifications in Internal Medicine, Endocrinology and Diabetology. From 2006 to 2012, Professor Blüher served as Head of the Clinical Research Group ‘Atherobesity,’ and since 2013, he has been Speaker of the Collaborative Research Center on obesity mechanisms.
    • Professor Blüher has won several awards, including the Obesity Research Award of the German Society for the Study of Obesity, the Ferdinand-Bertram-Prize of the German Diabetes Association, and the Rising Star Lecture at the 44th European Association for the Study of Diabetes (EASD) meeting. More recently, he received the Hans Christian Hagedorn Award from the German Diabetes Association in 2011 and the Minkowski Award from the EASD in 2015.
    • • References
      1. Blüher M, Aras M, Aronne LJ, Batterham RL, Giorgino F, Ji L, Pietiläinen KH, Schnell O, Tonchevska E, Wilding JPH. New insights into the treatment of obesity. Diabetes Obes Metab. 2023 Apr 13. doi: 10.1111/dom.15077.
      2. Blüher M. Metabolically Healthy Obesity. Endocr Rev. 2020 May 1;41(3):bnaa004.
    13:00-13:30 Nutrients-Stimulated Hormone-Based Pharmacotherapy for the Treatment of Obesity: Sparks from the Pipeline!

    Ania Jastreboff

    (Yale University, USA)
    11:40-11:50 Q&A
  • 14:00-15:30

    Symposium 6 : Holistic Approach to Obesity Management: Exploring Exercise, Metabolism, and Muscle Health

    Chairpersons : Yun-A Shin (Dankook University, Korea),
    Minchul Lee (CHA University, Korea)

    Organizer : Sewon Lee (Incheon National University, Korea), Minchul Lee (CHA University, Korea)

    • Symposium 6 aims to comprehensively explore the roles of exercise-induced mitochondrial controls in skeletal muscle, novel strategies in managing NAFLD focusing on muscle metabolism and exercise, and the impact of exercise intervention on sarcopenia and menopause in women. By taking a holistic approach, this symposium delves into various aspects of obesity management, examining the interplay between exercise, metabolism, and muscle health.
    14:00-14:25 Exercise-Induced Mitochondrial Controls in Skeletal Muscle

    Yuho Kim

    (University of Massachusetts-Lowell, USA)
    14:25-14:50 Lifestyle Strategies in the Management of MAFLD: The Role of Muscle Metabolism and Exercise

    Sechang Oh

    (R Professional University of Rehabilitation, Japan)
    14:50-15:15 Sarcopenia, Menopause, and Exercise Intervention in Women

    Young-Min Park

    (Incheon National University, Korea)
    15:15-15:30 Panel Discussion

    Hyo Youl Moon

    (Seoul National University, Korea),

    Kwangseok Hong

    (Chung-Ang University, Korea)
  • 15:30-15:40

    Break

  • 15:40-16:20

    Plenary Lecture 2

    Chairperson : Kee-Hyoung Lee (Korea University, Korea)

    Organizer : Yong Hee Hong (Soonchunhyang University, Korea)

    • Prof. Silva Arslanian is one of the global leaders in research on pediatric obesity and type 2 diabetes. She is a pediatric endocrinologist and a scientific director of the Center for Pediatric Research in Obesity and Metabolism at the University of Pittsburgh. She is the recipient of several prestigious awards, the latest being the 2023 American Diabetes Association Outstanding Achievement Award. In this keynote lecture, she will introduce new pharmacotherapeutic modalities for youth-onset type 2 diabetes, which has recently been on the rise globally as well as in Korea.
    15:40-16:10 Management of Youth Type 2 Diabetes: New Pharmacotherapeutic Modalities

    Silva Arslanian

    (University of Pittsburgh, USA)
    16:10-16:20 Q&A
  • 16:20-16:30

    Break

  • 16:30-18:00

    Symposium 10 : Obesity and Cancer

    Chairpersons : Hyuk-Sang Kwon (The Catholic University of Korea, Korea) ,
    Elaine Rush (Auckland University of Technology, New Zealand)

    Organizer: Hyung Jin Choi (Seoul National University, Republic of Korea)

    • In this session, we will delve into the intricate interplay between neuropsychology and obesity. Dr. Yun Ha Jeong from the Korea Brain Research Institute will discuss the impact of obesity and HDL concentration on the pathology of Alzheimer's disease (AD). Through an analysis of AD pathological changes in 5XFAD mice after obesity induction through a high-fat diet, Dr. Jeong presents a noteworthy phenomenon where the increase in HDL and APOA-I serum levels mitigates AD features, offering a potential avenue for novel therapeutic strategies.
    • Subsequently, Professor Kwang Wei Tham from Singapore Woodlands Health will elucidate how weight-related biases affect the physical, mental health, and obesity management of individuals. Lastly, Professor Youn Huh from Eulji University will explore the link between type 2 diabetes and dementia, emphasizing the growing relevance of preventing and managing these conditions, and discussing how type 2 diabetes escalates dementia risks, urging the derivation of preventive strategies based on research findings in light of the increasing prevalence of both diseases.
    16:30-16:55 Body Mass Index and Cancer Risk Among Adults With and Without Cardiometabolic Diseases

    Emma Fontvieille

    (International Agency for Research on Cancer, IARC/WHO, France)
    16:55-17:20 Metabolic Health and Risk of Breast Cancer: A Focus on Impact of Body Composition and Waist Circumference

    Mai Thi Xuan Tran

    (Hanyang University, Korea)
    17:20-17:45 Lifestyle, Obesity, and Cancer

    Wonsock Kim

    (Eulji University, Korea)
    17:45-18:00 Panel Discussion

    Young-Sang Kim

    (CHA University, Korea),

    Dong Wook Shin

    (Sungkyunkwan University, Korea)
  • 18:05-18:40

    EASO Presidential Lecture

    Chairperson : Sung Rae Kim (The Catholic University of Korea, Korea)

    Organizer : Jang Won Son (The Catholic University of Korea, Republic of Korea)

    • Professor Thiruma V. Arumugam, a distinguished researcher in the fields of physiology and pharmacology at La Trobe University, Australia, is pushing the boundaries of neuroscience and metabolism. In his upcoming lecture, he will discuss how his work on intermittent metabolic switching has enhanced our comprehension of its effect on brain health, paving the way for potential therapeutic interventions.
    • His recent publication in Theranostics, titled "Time-restricted feeding modulates the DNA methylation landscape, attenuates hallmark neuropathology and cognitive impairment in a mouse model of vascular dementia," has presented novel insights into the therapeutic potential of intermittent metabolic switching, offering promising strategies for managing and potentially reversing cognitive impairment in dementia.
    • Further expanding our understanding, Professor Arumugam's article in Cell Metabolism, "Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States," continues to revolutionize our perspective on the role of metabolism in brain aging.
    18:05-18:35 Management of Obesity in Older Adults

    Volkan Yumuk

    (Istanbul University-Cerrahpaşa, Turkey)
    09:00-09:10 Q&A
  • 07:30-08:20

    Breakfast Symposium 3

    Chairperson : Sang Yeoup Lee (Pusan National University, Korea)

    will be updated.
    07:30-08:20

  • 08:20-08:30

    Break

  • 08:30-09:10

    Keynote Lecture 1

    Chairperson : Min-Seon Kim (University of Ulsan, Korea)

    Organizer : Ki Woo Kim (Yonsei University, College of Dentistry, Korea)

    • In this session, Dr. Elmquist, Dean of Research at UT-Southwestern Medical Center and Director of the Center for Hypothalamic Research, will introduce a new platform for identifying key factors in obesity and metabolic regulation through the hypothalamus. He will explain the identified factors and present the latest research on how these factors influence whole-body homeostasis. This presentation will provide crucial insights into the mechanisms of hypothalamic function and the regulation of obesity and metabolic disorders, greatly benefiting conference attendees.
    • • References
      1. Coordination of metabolism, arousal, and reward by orexin/hypocretin neurons
      2. Leptin and brain-adipose crosstalks
    08:30-09:00 SF-1 Targets in the Hypothalamus: Novel Pathways Regulating Energy Balance and Metabolism

    Joel K. Elmquist

    (UT Southwestern Medical Center, USA)
    09:00-09:10 Q&A
  • 09:10-09:20

    Break

  • 09:20-10:50

    Symposium 3 : Possibilities and Prospects of Digital Therapeutics for Metabolic Diseases

    Chairpersons : Won-Young Lee(Sungkyunkwan University, Korea)

    Organizer : Sang Youl Rhee (Kyung Hee University, Korea)

    • This session will explore how digital therapeutics can contribute to treating and managing metabolic diseases. Prof. Sang Youl Rhee from Kyung Hee University will discuss the possibilities of digital therapeutics, Prof. Hyung Jin Choi from Seoul National University will delve into the psychological basis of their effectiveness, and Dr. Min Kyu Han from Kakao Healthcare will suggest ways to integrate digital therapeutics into conventional medical settings.
    09:20-09:45 Possibility of Digital Therapeutics for Treatment and Management of Metabolic Diseases

    Sang Youl Rhee

    (Kyung Hee University, Korea)
    09:45-10:10 Psychological Basis for the Effectiveness of Digital Therapeutics for Metabolic Diseases

    Hyung Jin Choi

    (Seoul National University, Korea)
    10:10-10:35 Suggestions for Integrating Digital Therapeutics into Conventional Medical Settings

    Min Kyu Han

    (Kakao Healthcare Corp., Korea)
    10:35-10:50 Panel Discussion

    Young Sang Lyu

    (Chosun University, Korea),

    Byoungduck Han

    (Korea University, Korea)
  • 10:50-11:00

    Break

  • 11:00-11:10

    Opening Address

  • 11:10-11:50

    Plenary Lecture 1

    Chairperson : Jeong Taek Woo (Kyung Hee University, Korea)

    Organizer: Soo Lim (Seoul National University, Republic of Korea)

    • Matthias Blüher is Head of the Obesity Outpatient Clinic for Adults at the University of Leipzig Department of Medicine in Leipzig, Germany. He is Professor of Molecular Endocrinology, with board certifications in Internal Medicine, Endocrinology and Diabetology. From 2006 to 2012, Professor Blüher served as Head of the Clinical Research Group ‘Atherobesity,’ and since 2013, he has been Speaker of the Collaborative Research Center on obesity mechanisms.
    • Professor Blüher has won several awards, including the Obesity Research Award of the German Society for the Study of Obesity, the Ferdinand-Bertram-Prize of the German Diabetes Association, and the Rising Star Lecture at the 44th European Association for the Study of Diabetes (EASD) meeting. More recently, he received the Hans Christian Hagedorn Award from the German Diabetes Association in 2011 and the Minkowski Award from the EASD in 2015.
    • • References
      1. Blüher M, Aras M, Aronne LJ, Batterham RL, Giorgino F, Ji L, Pietiläinen KH, Schnell O, Tonchevska E, Wilding JPH. New insights into the treatment of obesity. Diabetes Obes Metab. 2023 Apr 13. doi: 10.1111/dom.15077.
      2. Blüher M. Metabolically Healthy Obesity. Endocr Rev. 2020 May 1;41(3):bnaa004.
    11:10-11:40 GLP-1 Based Therapy of Obesity

    Michael A. Nauck

    (Ruhr-University Bochum, Germany)
    11:40-11:50 Q&A
  • 11:50-12:00

    Break

  • 12:00-13:00

    Luncheon Symposium 3

    Chairperson : Yong Sung Kim (Design Hospital, Korea)

    will be updated.
    12:00-13:00 The Earlier Use of SGLT2i, The Better Clinical Outcome in Obese T2D

    Jun Hwa Hong

    (Eulji University, Korea)
  • 13:00-13:40

    Special Scientific Session 1

    Organizer: Soo Lim (Seoul National University, Republic of Korea)

    • Matthias Blüher is Head of the Obesity Outpatient Clinic for Adults at the University of Leipzig Department of Medicine in Leipzig, Germany. He is Professor of Molecular Endocrinology, with board certifications in Internal Medicine, Endocrinology and Diabetology. From 2006 to 2012, Professor Blüher served as Head of the Clinical Research Group ‘Atherobesity,’ and since 2013, he has been Speaker of the Collaborative Research Center on obesity mechanisms.
    • Professor Blüher has won several awards, including the Obesity Research Award of the German Society for the Study of Obesity, the Ferdinand-Bertram-Prize of the German Diabetes Association, and the Rising Star Lecture at the 44th European Association for the Study of Diabetes (EASD) meeting. More recently, he received the Hans Christian Hagedorn Award from the German Diabetes Association in 2011 and the Minkowski Award from the EASD in 2015.
    • • References
      1. Blüher M, Aras M, Aronne LJ, Batterham RL, Giorgino F, Ji L, Pietiläinen KH, Schnell O, Tonchevska E, Wilding JPH. New insights into the treatment of obesity. Diabetes Obes Metab. 2023 Apr 13. doi: 10.1111/dom.15077.
      2. Blüher M. Metabolically Healthy Obesity. Endocr Rev. 2020 May 1;41(3):bnaa004.
    13:00-13:30 Nutrients-Stimulated Hormone-Based Pharmacotherapy for the Treatment of Obesity: Sparks from the Pipeline!

    Ania Jastreboff

    (Yale University, USA)
    11:40-11:50 Q&A
  • 14:00-15:30

    Symposium 7 : Lipid Remodeling and Adipocyte Biology in Metabolic Health and Disease

    Chairpersons : Yun-Hee Lee (Seoul National University, Korea) ,
    Dae Ho Lee (Gachon University, Korea)

    Organizer : Yun-Hee Lee (Seoul National University, College of Pharmacy)

    • This session brings together leading scientists to explore the complex interplay between adipose tissue biology, lipid metabolism, and metabolic diseases, offering insights into potential therapeutic strategies for obesity-related conditions. The first talk introduces the "Role of Lipid Droplets in Health and Cardiometabolic Disease”. The second presentation lipomatosis and its implications for aging and vascular health. Lastly, we will explore "The Functional Relevance of a Microbiome-Derived SCFA in Reprogramming Hepatic Lipid Metabolism”
    14:00-14:25 Role of Lipid Droplets in Health and Cardiometabolic Disease

    Emilio Mottillo

    (Henry Ford Hospital, USA)
    14:25-14:50 Stromal Transdifferentiation Drives Lipomatosis and Induces Extensive Vascular Remodeling in the Aging Human Lymph Node

    Maria Ulvmar

    (Uppsala University, Sweden)
    14:50-15:15 The Functional Relevance of a Microbiome-Derived SCFA in Reprogramming Hepatic Lipid Metabolism

    Dong Wook Choi

    (Korea University, Korea)
    15:15-15:30 Panel Discussion

    Ja Hyun Koo

    (Seoul National University, Korea),

    Ki Yong Hong

    (Seoul National University, Korea)
  • 15:30-15:40

    Break

  • 15:40-16:20

    Plenary Lecture 2

    Chairperson : Kee-Hyoung Lee (Korea University, Korea)

    Organizer : Yong Hee Hong (Soonchunhyang University, Korea)

    • Prof. Silva Arslanian is one of the global leaders in research on pediatric obesity and type 2 diabetes. She is a pediatric endocrinologist and a scientific director of the Center for Pediatric Research in Obesity and Metabolism at the University of Pittsburgh. She is the recipient of several prestigious awards, the latest being the 2023 American Diabetes Association Outstanding Achievement Award. In this keynote lecture, she will introduce new pharmacotherapeutic modalities for youth-onset type 2 diabetes, which has recently been on the rise globally as well as in Korea.
    15:40-16:10 Management of Youth Type 2 Diabetes: New Pharmacotherapeutic Modalities

    Silva Arslanian

    (University of Pittsburgh, USA)
    16:10-16:20 Q&A
  • 16:20-16:30

    Break

  • 16:30-18:00

    Symposium 11 : Perspectives in Digital Nutrition Care for Obesity

    Chairpersons : Jeong Hyun Lim (Seoul National University, Korea) ,
    Yoonju Song (The Catholic University of Korea, Korea)

    Organizer : Jeong Hyun Lim (Seoul National University, Korea), SuJin Song (Hannam University, Korea), Oh Yoen Kim (Dong-A University, Korea), Hyunjung Lim (Kyung Hee University, Korea)

    • In this session, we will discuss the effective application of digital health care and telenutrition for the prevention and management of obesity. The first speaker, Prof. Wen Peng of Qinghai University, will review relevant studies conducted in Asia, and the second speaker, Prof. Melissa Ventura Marra of West Virginia University, will introduce the effects of telenutrition based on the results of clinical studies in the United States. The last speaker, Dr. Shin Ok Park of Noom Korea, will give a lecture on the pros and cons of applying telenutrition in weight management and future prospects.
    • • References
      1. Liang F, Yang X, Peng W, Zhen S, Cao W, Li Q, Xiao Z, Gong M, Wang Y, Gu D. Applications of digital health approaches for cardiometabolic diseases prevention and management in the Western Pacific region. Lancet Reg Health West Pac. 2023;43:100817
      2. Ventura Marra M, Lilly CL, Nelson KR, Woofter DR, Malone J. A Pilot Randomized Controlled Trial of a Telenutrition Weight Loss Intervention in Middle-Aged and Older Men with Multiple Risk Factors for Cardiovascular Disease. Nutrients. 2019;11(2):229
    16:30-16:55 Applications of Digital Health and Nutrition Approaches for Obesity Prevention and Management in the Western Pacific Region

    Wen Peng

    (Qinghai University, China)
    16:55-17:20 Exploring the Landscape of Telenutrition in Obesity Management

    Melissa Ventura-Marra

    (West Virginia University, USA)
    17:20-17:45 Telenutrition for Weight Management: Benefits, Limits, and Future Perspectives

    Shinok Park

    (Noom Korea, Korea)
    17:45-18:00 Panel Discussion
  • 18:05-18:40

    EASO Presidential Lecture

    Chairperson : Sung Rae Kim (The Catholic University of Korea, Korea)

    Organizer : Jang Won Son (The Catholic University of Korea, Republic of Korea)

    • Professor Thiruma V. Arumugam, a distinguished researcher in the fields of physiology and pharmacology at La Trobe University, Australia, is pushing the boundaries of neuroscience and metabolism. In his upcoming lecture, he will discuss how his work on intermittent metabolic switching has enhanced our comprehension of its effect on brain health, paving the way for potential therapeutic interventions.
    • His recent publication in Theranostics, titled "Time-restricted feeding modulates the DNA methylation landscape, attenuates hallmark neuropathology and cognitive impairment in a mouse model of vascular dementia," has presented novel insights into the therapeutic potential of intermittent metabolic switching, offering promising strategies for managing and potentially reversing cognitive impairment in dementia.
    • Further expanding our understanding, Professor Arumugam's article in Cell Metabolism, "Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States," continues to revolutionize our perspective on the role of metabolism in brain aging.
    18:05-18:35 Management of Obesity in Older Adults

    Volkan Yumuk

    (Istanbul University-Cerrahpaşa, Turkey)
    09:00-09:10 Q&A
  • 09:20-10:50

    Symposium 4 : International Collaboration 1

    Chairpersons : Kun-Ho Yoon (The Catholic University of Korea, Korea) ,
    Michele Mae Ann Yuen (Queen Mary Hospital, Hong Kong, China)

    Organizer : Chang Hee Jung (University of Ulsan, Republic of Korea)

    • Numerous studies have been conducted on the association between the decline in muscle mass, known as sarcopenia, and cardio-metabolic diseases. Recently, there has been a growing interest in the quality of muscles, as research findings suggest that muscle quality is important in various aspects, in addition to muscle mass reduction.
    • Myosteatosis, an important factor determining muscle quality, has emerged as a risk factor for new cardio-metabolic diseases beyond sarcopenia. In this session, we aim to explore the prevalence of myosteatosis and its relationship with cardio-metabolic diseases. Furthermore, we aim to investigate its significance by comparing it with the accumulation of other ectopic fats.
    • • References
      1. Age-related changes in muscle quality and development of diagnostic cutoff points for myosteatosis in lumbar skeletal muscles
      measured by CT scan Clin Nutr. 2021 Jun;40(6):4022-4028.
      2. Association between sarcopenic obesity and poor muscle quality based on muscle quality map and abdominal computed tomography. Obesity (Silver Spring). 2023 Jun;31(6):1547-1557.
      Fat Distribution Patterns and Future Type 2 Diabetes Diabetes. 2022 Sep 1;71(9):1937-1945
    09:20-09:45 Sex Differences in Adipose Tissue Metabolism as It Relates to Risk of Diabetes

    Michael D. Jensen

    (Mayo College of Medicine, USA)
    09:45-10:10 The Role of GIP/or Glucagon Receptor Agonism in the Treatment of Obesity

    Michael A. Nauck

    (Ruhr-University Bochum, Germany)
    10:10-10:35 Treatment of Metabolic Syndrome Complications with Adiponectin Therapeutics

    Gary Sweeney

    (York University, Canada)
    10:35-10:50 Panel Discussion
  • 12:00-13:00

    Luncheon Symposium 4

    Chairperson : Hyun Ho Shin (Asan Chungmu Hospital, Korea)

    will be updated.
    12:00-13:00 Real World Evidence of Phentermine Plus Topiramate ER in Korean : Efficacy and Safety

    Kyoung Min Kim

    (Yonsei University, Korea)
  • 13:00-14:00

    Oral Presentation 1

    Chairpersons : Yeong Sook Yoon (Inje University, Korea) ,
    Yang-Im Hur (CHA University, Korea)

    will be updated.
    13:00-13:10

    13:10-13:20

    13:20-13:30

    13:30-13:40

    13:40-13:50

  • 14:00-15:30

    Symposium 8 : Medical Condition Change After Bariatric Surgery

    Chairpersons : In Ju Kim (Pusan National University, Korea),
    Sung Il Choi (Kyung Hee University, Korea)

    will be updated.
    14:00-14:25 Cardiovascular Disease and Hypertension Change After Bariatric Surgery

    Kanokkan Tepmalai

    (Chiang Mai University, Thailand)
    14:25-14:50 Gastrointestinal Motility and Function Change After Bariatric Surgery

    Jong-Han Kim

    (Korea University, Korea)
    14:50-15:15 Bariatric Surgery and its Impact on Cancer Risk Reduction

    Moon-Won Yoo

    (University of Ulsan, Korea)
    15:15-15:30 Panel Discussion

    Sungbae Lee

    (Incheon Sejong Hospital, Korea)
  • 16:30-18:00

    Symposium 12 : Childhood Obesity is a Chronic Disease Demanding Specific Health Care

    Chairpersons : Il Tae Hwang (Hallym University, Korea),
    Kye Sik Shim (Kyung Hee University, Korea)

    Organizer: Jaehyun Kim (Seoul National University, Korea), Yong Hee Hong (Soonchunhyang University, Korea)

    • Pediatric obesity is a chronic disease that requires long-term management throughout life and must be managed according to the special characteristics of children and adolescents. First, we would like to find out how the prevention and management of obesity in children and adolescents is performing in Korea and how it should be managed. Next, we will figure out nutritional intervention strategies for obesity in children and adolescents and the role of nutritionists, and finally, we will look at adolescent obesity, which is difficult to manage and requires a complex approach from multiple aspects.
    • • References
      1. Bensignor MO, Arslanian S, Vajravelu ME. Semaglutide for management of obesity in adolescents: efficacy, safety, and considerations for clinical practice. Curr Opin Pediatr. 2024 May 16. doi: 10.1097/MOP.0000000000001365.
      2. Hannon TS, Arslanian SA. Obesity in Adolescents. N Engl J Med. 2023 Jul 20;389(3):251-261
    16:30-16:55 Pediatric Obesity Prevention and Management in Korea: How to Do It in the Real World?

    Sochung Chung

    (Konkuk University, Korea)
    16:55-17:20 Nutritional Intervention Strategies for Childhood Obesity: The Role of the Dietitian

    Mary Easaw

    (Cardiac Vascular Sentral Kuala Lumpur, Malaysia)
    17:20-17:45 Adolescent Obesity: Complexities of Chronic Disease

    Silva Arslanian

    (University of Pittsburgh, USA)
    17:45-18:00 Panel Discussion

    Yeo-Jin Hong

    (Korea University, Korea) ,

    Hwal Rim Jeong

    (Soonchunhyang University, Korea)
  • 09:20-10:50

    Sponsored Session 1 : SELECT the Outcome Beyond Weight Loss

    Chairpersons : Jae-Heon Kang (Sungkyunkwan University, Korea),
    Sang Yong Kim (Chosun University, Korea)

    will be updated.
    09:20-09:50 SELECTing the Clinical Outcome of Semaglutide 2.4mg from its Physiological Benefits

    Filip K. Knop

    (University of Copenhagen, Denmark)
    09:50-10:20 STEPping Forward: Managing Weight for East Asian Population with Obesity

    Sang Yeoup Lee

    (Pusan National University, Korea)
    10:20-10:50

    Darae Kim

    (Sungkyunkwwan University, Korea)
  • 13:00-14:00

    Oral Presentation 2

    Chairpersons : Jung Hwan Park (Hanyang University, Korea) ,
    Jun Hwa Hong (Eulji university, Korea)

    will be updated.
    13:00-13:10

    13:10-13:20

    13:20-13:30

    13:30-13:40

    13:40-13:50

  • 14:00-15:30

    Sponsored Session 2 : Obesity Management with Combination Phentermine Plus Topiramate from Strategy to Practice

    Chairpersons : Ji A Seo (Korea University, Korea),
    Bumjo Oh(Seoul National University, Korea)

    will be updated.
    14:00-14:30 A FAQ-Based Approach to Prescription of Combination Phentermine Plus Topiramate

    Jee-Hyun Kang

    (Konyang University, Korea)
    14:30-15:00 Weight Maintenance Strategy for Obesity Drug Therapy; Combination Phentermine Plus Topiramate

    Yoon Jeong Cho

    (Daegu Catholic University, Korea)
    15:00-15:30

    Jong Han Choi

    (Konkuk University, Korea)
  • 16:30-18:00

    Joint Symposium KSSO-EASO

    Chairpersons : Volkan Yumuk (Istanbul University-Cerrahpaşa, Turkey),
    Cheol-Young Park (Sungkyunkwan University, Korea)

    16:30-17:00 ACTION Teens: Barriers for Adolescents Living with Obesity to Weight Management in the UK

    Jason Halford

    (University of Leeds, UK)
    17:00-17:30 Ectopic Fat Dynamics: Unraveling the Interplay Between Myosteatosis and Cardio-Metabolic Health

    Chang Hee Jung

    (University of Ulsan, Korea)
    17:30-18:00

    Barbara McGowan

    (Guy's and St Thomas' NHS Foundation Trust, UK)
  • 13:00-13:35

    Guided Poster Presentation 1

    Chairperson : Ga Eun Nam (Korea University, Korea)

    will be updated.
    13:00-13:07

    13:07-13:14

    13:14-13:21

    13:21-13:28

    13:28-13:35

  • 18:40-

    Congress Banquet *Invited Only

  • 07:30-08:20

    Breakfast Symposium 4

    Chairperson : Sung Ho Han (Dong-A University, Korea)

    will be updated.
    07:30-08:20 TRUE-BUDDY Combination Therapy: Benefits for Beta Cells, Insulin Resistance and Diabetic Complications

    Chang Hee Jung

    (University of Ulsan, Korea)
  • 08:20-08:30

    Break

  • 08:30-09:10

    Keynote Lecture 2

    Chairperson : Hye Soon Park (University of Ulsan, Korea)

    Organizer: Jae Geun Kim (Incheon National University, Republic of Korea)

    • Professor Tamas Horvath is Chair of the Department of Comparative Medicine at Yale University School of Medicine in the United States and one of the leading researchers in the field of study on the hypothalamic control of energy homeostasis. In particular, his research on the regulation of synaptic plasticity by AgRP neurons in hypothalamic neuronal circuitries is one of his most noteworthy accomplishments. In this session, Professor Horvath will introduce the role of hypothalamic AgRP neurons that can be applied to obesity treatment.
    • • References
      1. Hunger-promoting AgRP neurons trigger an astrocyte-mediated feed-forward autoactivation loop in mice. J Clin Invest. 2021
      2. AgRP neurons control compulsive exercise and survival in an activity-based anorexia model. Nature Metabolism. 2020.
    08:30-09:00 Cardiometabolic Health: Importance of Lifestyle Vital Signs

    Jean-Pierre Després

    (VITAM - Research Centre on Sustainable Health, Canada)
    09:00-09:10 Q&A
  • 09:10-09:20

    Break

  • 09:20-10:50

    Symposium 13 : Obesity Related Comorbidity-Fatty Liver

    Chairpersons : Chang Beom Lee (Hanyang University, Korea),
    Geeta Appannah (University Putra Malaysia, Malaysia)

    Organizer : Jun Hwa Hong (Eulji University, Republic of Korea)

    • In this session, we will explore the relationship between fatty liver associated with obesity and its diverse complications. Considering the recently increasing prevalence and growing interest in treatment of chronic kidney disease due to the introduction of SGLT2i, Professor Sang-Man Jin from Sungkyunkwan University School of Medicine will present data analyzing non-alcoholic fatty liver disease (NAFLD) and metabolic dysfunction-associated fatty liver disease (MAFLD) in relation to the cause of incident chronic kidney disease.
    • Professor Ming-Hua Zheng from China will analyze and present differences in implications for cardiovascular risk based on the cause of fatty liver. Particularly, Professor Bo-Kyung Koo from Seoul National University College of Medicine will explore data on factors related to the prognosis of cardiovascular and kidney disease, given the diverse impacts that complications in NAFLD patients have on cardiovascular and kidney conditions as well as liver condition.
    • We hope this session will assist you in managing the complications associated with MAFLD.
    • • References
      1. MAFLD and NAFLD in the prediction of incident chronic kidney disease. Sci Rep. 2023 Jan 31;13(1):1796.
      2. Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention. Cardiovasc Diabetol. 2022 Dec 3;21(1):270.
    09:20-09:45 Impact of Adipocyte Death on Steatotic Liver Disease (SLD)

    Seung-Jin Kim

    (Kangwon National University, Korea)
    09:45-10:10 GDF15 and Fatty Liver

    Hua Wang

    (First Affiliated Hospital of Anhui Medical University, China)
    10:10-10:35 TZD and SGLT2i Combination for Fatty Liver Management

    Jun Hwa Hong

    (Eulji University, Korea)
    10:35-10:50 Panel Discussion

    Bo Kyung Koo

    (Seoul National University, Korea),

    Youn Huh

    (Eulji University, Korea)
  • 10:50-11:00

    Break

  • 11:00-11:40

    Presidential Lecture

    Chairperson : Kwang-Won Kim (Gachon University, Korea)

    Organizer: Soo Lim (Seoul National University, Republic of Korea), Jun Hwa Hong (Eulji University, Republic of Korea)

    • The interplay between adipose tissue's function as an energy reservoir and an endocrine organ is crucial for maintaining metabolic health. A key player in this dynamic balance is leptin, a hormone whose regulation is tightly linked to fat mass. Here we will discuss the multifaceted role of LATS1/2-YAP/TAZ signaling in regulating adipocyte plasticity and leptin production to maintain metabolic homeostasis.
    • • References
      1. Sethi, J.K. and A.J. Vidal-Puig, Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res, 2007. 48(6): p. 1253-62.
      2. Halder, G. and R.L. Johnson, Hippo signaling: growth control and beyond. Development, 2011. 138(1): p. 9-22.
    11:00-11:30 Obesity and Fatty Liver: Common but Ignored

    Cheol-Young Park

    (Sungkyunkwan University, Korea)
    11:30-11:40 Q&A

  • 11:40-11:50

    Break

  • 11:50-12:50

    Luncheon Symposium 5

    Chairperson : Seung Joon Oh (Kyung Hee University, Korea)

    will be updated.
    11:50-12:50

    W. Timothy Garvey

    (University of Alabama at Birmingham, USA)
  • 12:50-13:30

    Special Scientific Session 2

    Organizer: Soo Lim (Seoul National University, Republic of Korea)

    • Matthias Blüher is Head of the Obesity Outpatient Clinic for Adults at the University of Leipzig Department of Medicine in Leipzig, Germany. He is Professor of Molecular Endocrinology, with board certifications in Internal Medicine, Endocrinology and Diabetology. From 2006 to 2012, Professor Blüher served as Head of the Clinical Research Group ‘Atherobesity,’ and since 2013, he has been Speaker of the Collaborative Research Center on obesity mechanisms.
    • Professor Blüher has won several awards, including the Obesity Research Award of the German Society for the Study of Obesity, the Ferdinand-Bertram-Prize of the German Diabetes Association, and the Rising Star Lecture at the 44th European Association for the Study of Diabetes (EASD) meeting. More recently, he received the Hans Christian Hagedorn Award from the German Diabetes Association in 2011 and the Minkowski Award from the EASD in 2015.
    • • References
      1. Blüher M, Aras M, Aronne LJ, Batterham RL, Giorgino F, Ji L, Pietiläinen KH, Schnell O, Tonchevska E, Wilding JPH. New insights into the treatment of obesity. Diabetes Obes Metab. 2023 Apr 13. doi: 10.1111/dom.15077.
      2. Blüher M. Metabolically Healthy Obesity. Endocr Rev. 2020 May 1;41(3):bnaa004.
    12:50-13:20 Clinical Implication of GLP-1 Receptor Agonists and SGLT2 Inhibitors from a Cardiometabolic Perspective

    Soo Lim

    (Seoul National University, Korea)
    13:20-13:30 Q&A
  • 13:50-14:30

    Plenary Lecture 3

    Chairperson : Kwan Woo Lee (Ajou University, Korea)

    Organizer: Il-Young Kim (Gachon University School of Medicine, Korea)

    • Prof. William Evans is widely respected as the world’s foremost authority in human muscle aging research. He was the first to describe the condition called sarcopenia, the age-related loss of muscle mass and strength. Muscle plays a central role in physiological metabolism beyond its role in physical function and various clinical conditions such as cancer, diabetes, insulin resistance, and obesity. Particularly in the context of weight management, muscle plays a key role in energy metabolism as loss of muscle mass with advancing age results in a substantial decrease in basal metabolic rate. In this keynote lecture, Prof. Evans will discuss the importance of muscle mass and metabolism on energy metabolism and functional capacity. Furthermore, Prof. Evans will introduce new methods for the evaluation of muscle mass that now enable demonstration of the importance of muscle mass and its association with poor functional status, risk of disability, hip fracture, and mortality.
    • • References
      1. Evans WJ, Cawthon PM. D(3)Creatine Dilution as a Direct, Non-invasive and Accurate Measurement of Muscle Mass for Aging Research. Calcif Tissue Int. 2023
      2. Cawthon PM, Blackwell T, Cummings SR, et al. Muscle mass assessed by D3-Creatine dilution method and incident self-reported disability and mortality in a prospective observational study of community dwelling ol0der men. J Gerontol A Biol Sci Med Sci. 2020
      3. Orwoll ES, Peters KE, Hellerstein M, Cummings SR, Evans WJ, Cawthon PM. The Importance of Muscle Versus Fat Mass in Sarcopenic Obesity: A Re-evaluation Using D3-Creatine Muscle Mass Versus DXA Lean Mass Measurements. J Gerontol A Biol Sci Med Sci. 2020
    13:50-14:20 How Muscle Mass and Metabolism Affects Energy Metabolism and Functional Capacity

    William Evans

    (University of California, Berkeley, USA)
    14:20-14:30 Q&A
  • 14:30-15:10

    Keynote Lecture 3

    Chairperson : Moon-Kyu Lee (Eulji University, Korea)

    Organizer: Soo Lim (Seoul National University, Republic of Korea)

    • Obesity is not only a serious disease in itself, but also a health risk factor that causes various diseases, so governmental plan and policy cooperation are needed. Korean government established and announced the first national obesity management comprehensive plan in 2018 to provide an opportunity to raise public awareness of the importance of obesity prevention and management and to monitor the pregress. In this lecture, I would like to introduce the past, present and future of Korea's national obesity strategy.
    14:30-15:00 Human Adipose Tissue Metabolism: What Happens with Obesity

    Michael D. Jensen

    (Mayo College of Medicine,USA)
    15:00-15:10 Q&A
  • 15:10-15:20

    Break

  • 15:20-16:50

    Symposium 17 : Incretin Therapy from MARS, Bariatric Surgery from VENUS

    will be updated.
    15:20-15:45 Incretin-Based Therapy Before Bariatric Surgery: Will It Be Helpful?

    Mi-Kyung Kim

    (Keimyung University, Korea)
    15:45-16:10 Incretin-Based Therapy after Bariatric-Metabolic Surgery: When and How Long?

    Po-Chih Chang

    (National Sun Yat-Sen University, Taiwan)
    16:10-16:35 Incretin-Based Therapy—Will It Be Better Than Bariatric Surgery Alone

    Barbara McGowan

    (Guy's and St Thomas' NHS Foundation Trust, UK)
    16:35-16:50 Panel Discussion

    Kyung-Soo Kim

    (CHA University, Korea),

    Jun Sung Moon

    (Yeungnam University, Korea)
  • 16:50-17:00

    Break

  • 17:00-17:40

    Plenary Lecture 4

    Chairperson : Kyu Rae Lee (Gachon University, Korea)

    will be updated.
    17:00-17:30 Semaglutide, a Second-Generation Obesity Medication for the Treatment and Prevention of Cardiometabolic Disease

    W. Timothy Garvey

    (University of Alabama at Birmingham, USA)
    17:30-17:40 Q&A
  • 17:40-18:00

    Closing & Award Ceremony

  • 07:30-08:20

    Breakfast Symposium 5

    Chairperson : Sung-Hoon Kim (Mizmedi Hospital, Korea)

    will be updated.
    07:30-08:20 Revolutionizing Obesity Care

    Jang Won Son

    (The Catholic University of Korea, Korea)
  • 08:20-08:30

    Break

  • 08:30-09:10

    Keynote Lecture 2

    Chairperson : Hye Soon Park (University of Ulsan, Korea)

    Organizer: Soo Lim (Seoul National University, Republic of Korea)

    • Obesity is not only a serious disease in itself, but also a health risk factor that causes various diseases, so governmental plan and policy cooperation are needed. Korean government established and announced the first national obesity management comprehensive plan in 2018 to provide an opportunity to raise public awareness of the importance of obesity prevention and management and to monitor the pregress. In this lecture, I would like to introduce the past, present and future of Korea's national obesity strategy.
    08:30-09:00 Cardiometabolic Health: Importance of Lifestyle Vital Signs

    Jean-Pierre Després

    (VITAM - Research Centre on Sustainable Health, Canada)
    09:00-09:10 Q&A
  • 09:10-09:20

    Break

  • 09:20-10:50

    Symposium 14 : Understanding Aging Skeletal Muscle and Dynamics

    Chairpersons : Kijin Kim (Keimyung University, Korea),
    Jae Myoung Suh (KAIST, Korea)

    Organizer: Il-Young Kim (Gachon University, Korea), Seung-Hwan Lee (The Catholic University of Korea, Korea)

    • Sarcopenia is the age-associated loss of muscle mass and strength and is characterized by anabolic resistance, i.e., blunted anabolic response (muscle protein synthesis) to exercise or nutrition, which (in)directly affects other clinical conditions. To discover effective therapeutics, it is of important 1) to understand dysregulated dynamics of aging muscle proteome and 2) to acutely assess muscle mass to evaluate the efficacy of therapeutic candidates, both of which were largely underappreciated over the past decades. In this symposium, these issues will be discussed by two world’s foremost authorities, Prof. Evans (for direct muscle mass) and Prof. Hellerstein (for dynamics of muscle proteome), respectively. Lastly, Prof. Kim will discuss anabolic resistance to exercise in aging muscle and the potential therapeutic effect of balanced essential amino acids.
    • • References
      1. Evans WJ, Simplified definition of sarcopenia: muscle mass/body weight, The Journal of Nutrition, Health and Aging 2024
      2. Shankaran M et al., Circulating protein synthesis rates reveal skeletal muscle proteome dynamics, J Clin Invest 2016
      3. Jang et al., Free essential amino acid feeding improves endurance during resistance training via DRP1-dependent mitochondrial remodelling. JCSM 2024
    09:20-09:45 Sarcopenia: New Insights for a Unified Definition

    William Evans

    (University of California, Berkeley, USA)
    09:45-10:10 Understanding Skeletal Muscle Mass, Protein Dynamics, Regulation and Function Using New Tracer Techniques

    Marc Hellerstein

    (University of California, Berkeley, USA)
    10:10-10:35 Overcoming Anabolic Resistance to Exercise in Sarcopenia: Role of Free Essential Amino Acids

    Il-Young Kim

    (Gachon University, Korea)
    10:35-10:50 Panel Discussion

    Seung-Hwan Lee

    (The Catholic University of Korea, Korea) ,

    Justin Y. Jeon

    (Yonsei University, Korea)
  • 10:50-11:00

    Break

  • 11:00-11:40

    Presidential Lecture

    Chairperson : Kwang-Won Kim (Gachon University, Korea)

    Organizer: Soo Lim (Seoul National University, Republic of Korea), Jun Hwa Hong (Eulji University, Republic of Korea)

    • The interplay between adipose tissue's function as an energy reservoir and an endocrine organ is crucial for maintaining metabolic health. A key player in this dynamic balance is leptin, a hormone whose regulation is tightly linked to fat mass. Here we will discuss the multifaceted role of LATS1/2-YAP/TAZ signaling in regulating adipocyte plasticity and leptin production to maintain metabolic homeostasis.
    • • References
      1. Sethi, J.K. and A.J. Vidal-Puig, Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res, 2007. 48(6): p. 1253-62.
      2. Halder, G. and R.L. Johnson, Hippo signaling: growth control and beyond. Development, 2011. 138(1): p. 9-22.
    11:00-11:30 Obesity and Fatty Liver: Common but Ignored

    Cheol-Young Park

    (Sungkyunkwan University, Korea)
    11:30-11:40 Q&A

  • 11:40-11:50

    Break

  • 11:50-12:50

    Luncheon Symposium 6

    Chairperson : Sung-Soo Kim (Chungnam National University, Korea)

    will be updated.
    11:50-12:50 The Review of Combination Phentermine Plus Topiramate for Chronic Weight Management

    Kyung Soo Kim

    (CHA University, Korea)
  • 12:50-13:30

    Special Scientific Session 2

    Organizer: Soo Lim (Seoul National University, Republic of Korea)

    • Matthias Blüher is Head of the Obesity Outpatient Clinic for Adults at the University of Leipzig Department of Medicine in Leipzig, Germany. He is Professor of Molecular Endocrinology, with board certifications in Internal Medicine, Endocrinology and Diabetology. From 2006 to 2012, Professor Blüher served as Head of the Clinical Research Group ‘Atherobesity,’ and since 2013, he has been Speaker of the Collaborative Research Center on obesity mechanisms.
    • Professor Blüher has won several awards, including the Obesity Research Award of the German Society for the Study of Obesity, the Ferdinand-Bertram-Prize of the German Diabetes Association, and the Rising Star Lecture at the 44th European Association for the Study of Diabetes (EASD) meeting. More recently, he received the Hans Christian Hagedorn Award from the German Diabetes Association in 2011 and the Minkowski Award from the EASD in 2015.
    • • References
      1. Blüher M, Aras M, Aronne LJ, Batterham RL, Giorgino F, Ji L, Pietiläinen KH, Schnell O, Tonchevska E, Wilding JPH. New insights into the treatment of obesity. Diabetes Obes Metab. 2023 Apr 13. doi: 10.1111/dom.15077.
      2. Blüher M. Metabolically Healthy Obesity. Endocr Rev. 2020 May 1;41(3):bnaa004.
    12:50-13:20 Clinical Implication of GLP-1 Receptor Agonists and SGLT2 Inhibitors from a Cardiometabolic Perspective

    Soo Lim

    (Seoul National University, Korea)
    13:20-13:30 Q&A
  • 13:50-14:30

    Plenary Lecture 3

    Chairperson : Kwan Woo Lee (Ajou University, Korea)

    Organizer: Il-Young Kim (Gachon University School of Medicine, Korea)

    • Prof. William Evans is widely respected as the world’s foremost authority in human muscle aging research. He was the first to describe the condition called sarcopenia, the age-related loss of muscle mass and strength. Muscle plays a central role in physiological metabolism beyond its role in physical function and various clinical conditions such as cancer, diabetes, insulin resistance, and obesity. Particularly in the context of weight management, muscle plays a key role in energy metabolism as loss of muscle mass with advancing age results in a substantial decrease in basal metabolic rate. In this keynote lecture, Prof. Evans will discuss the importance of muscle mass and metabolism on energy metabolism and functional capacity. Furthermore, Prof. Evans will introduce new methods for the evaluation of muscle mass that now enable demonstration of the importance of muscle mass and its association with poor functional status, risk of disability, hip fracture, and mortality.
    • • References
      1. Evans WJ, Cawthon PM. D(3)Creatine Dilution as a Direct, Non-invasive and Accurate Measurement of Muscle Mass for Aging Research. Calcif Tissue Int. 2023
      2. Cawthon PM, Blackwell T, Cummings SR, et al. Muscle mass assessed by D3-Creatine dilution method and incident self-reported disability and mortality in a prospective observational study of community dwelling ol0der men. J Gerontol A Biol Sci Med Sci. 2020
      3. Orwoll ES, Peters KE, Hellerstein M, Cummings SR, Evans WJ, Cawthon PM. The Importance of Muscle Versus Fat Mass in Sarcopenic Obesity: A Re-evaluation Using D3-Creatine Muscle Mass Versus DXA Lean Mass Measurements. J Gerontol A Biol Sci Med Sci. 2020
    13:50-14:20 How Muscle Mass and Metabolism Affects Energy Metabolism and Functional Capacity

    William Evans

    (University of California, Berkeley, USA)
    14:20-14:30 Q&A
  • 14:30-15:10

    Keynote Lecture 3

    Chairperson : Moon-Kyu Lee (Eulji University, Korea)

    Organizer: Soo Lim (Seoul National University, Republic of Korea)

    • Obesity is not only a serious disease in itself, but also a health risk factor that causes various diseases, so governmental plan and policy cooperation are needed. Korean government established and announced the first national obesity management comprehensive plan in 2018 to provide an opportunity to raise public awareness of the importance of obesity prevention and management and to monitor the pregress. In this lecture, I would like to introduce the past, present and future of Korea's national obesity strategy.
    14:30-15:00 Human Adipose Tissue Metabolism: What Happens with Obesity

    Michael D. Jensen

    (Mayo College of Medicine,USAa)
    15:00-15:10 Q&A
  • 15:10-15:20

    Break

  • 15:20-16:50

    Symposium 18 : Cracking the Neural Code: Understanding Obesity through the Hypothalamus, Brain Stem, and Vagus Pathways

    Chairpersons : Ki Woo Kim (Yonsei University, Korea),
    Hyung Jin Choi (Seoul National University, Korea)

    Organizer : Hyung Jin Choi (Seoul National University, Korea)

    • The brainstem and hypothalamus intricately orchestrate physiological processes, including appetite regulation and body weight maintenance, by modulating the hunger and satiety. Prof. Jo-Eun Son will elucidate the hypothalamus's mechanism in the genetic determinants of human obesity, Prof. Chen Ran will reveal on the neural encoding of internal senses within the brainstem, and Prof. Zhan Cheng will discuss the function of brainstem catecholaminergic neurons in the regulation of energy homeostasis.
    • • References
      1. 2021 Nature Metabolism. Irx3 and Irx5 in Ins2-Cre+ cells regulate hypothalamic postnatal neurogenesis and leptin response
      2021 Science Advances. Ectopic expression of Irx3 and Irx5 in the paraventricular nucleus of the hypothalamus contributes to defects in Sim1 haploinsufficiency
      2. 2022 Nature. A brainstem map for visceral sensations
      3. 2024 Nature Neuroscience. Fasting-activated ventrolateral medulla neurons regulate T cell homing and suppress autoimmune disease in mice
      2023 Cell Reports. AgRP neurons are not indispensable for body weight maintenance in adult mice
    15:20-15:45 Hypothalamic Function of IRX3 and IRX5, Genetic Determinants of Human Obesity

    Joe Eun Son

    (Kyungpook National University, Korea)
    15:45-16:10 The Coding of Internal Senses in the Brainstem

    Chen Ran

    (The Scripps Research Institute, USA)
    16:10-16:35 Roles of Brainstem Catecholaminergic Neurons in Control of Energy Homeostasis

    Cheng Zhan

    (University of Science and Technology of China, China)
    16:35-16:50 Panel Discussion

    Yong Taek Jeong

    (Korea University, Korea),

    Chan Hee Lee

    (Hallym University, Korea)
  • 16:50-17:00

    Break

  • 17:00-17:40

    Plenary Lecture 4

    Chairperson : Kyu Rae Lee (Gachon University, Korea)

    will be updated.
    17:00-17:30 Semaglutide, a Second-Generation Obesity Medication for the Treatment and Prevention of Cardiometabolic Disease

    W. Timothy Garvey

    (University of Alabama at Birmingham, USA)
    17:30-17:40 Q&A
  • 17:40-18:00

    Closing & Award Ceremony

  • 07:30-08:20

    Breakfast Symposium 6

    Chairperson : Keun-Mi Lee (Yeungnam University, Korea)

    will be updated.
    07:30-08:20 TRUE-BUDDY Combination Therapy: Benefits for Beta Cells, Insulin Resistance and Diabetic Complications

    Seung-Hwan Lee

    (The Catholic University of Korea, Korea)
  • 08:20-08:30

    Break

  • 08:30-09:10

    Keynote Lecture 2

    Chairperson : Hye Soon Park (University of Ulsan, Korea)

    Organizer: Jae Geun Kim (Incheon National University, Republic of Korea)

    • Professor Tamas Horvath is Chair of the Department of Comparative Medicine at Yale University School of Medicine in the United States and one of the leading researchers in the field of study on the hypothalamic control of energy homeostasis. In particular, his research on the regulation of synaptic plasticity by AgRP neurons in hypothalamic neuronal circuitries is one of his most noteworthy accomplishments. In this session, Professor Horvath will introduce the role of hypothalamic AgRP neurons that can be applied to obesity treatment.
    • • References
      1. Hunger-promoting AgRP neurons trigger an astrocyte-mediated feed-forward autoactivation loop in mice. J Clin Invest. 2021
      2. AgRP neurons control compulsive exercise and survival in an activity-based anorexia model. Nature Metabolism. 2020.
    08:30-09:00 Cardiometabolic Health: Importance of Lifestyle Vital Signs

    Jean-Pierre Després

    (VITAM - Research Centre on Sustainable Health, Canada)
    09:00-09:10 Q&A
  • 09:10-09:20

    Break

  • 09:20-10:50

    Symposium 15 : Diet Quality and Weight Regulation

    Chairpersons : Doo-Man Kim (Hallym University, Korea) ,
    Eun Mi Kim (Sungkyunkwan University, Korea)

    Organizer: Hyunjung Lim (Kyung Hee University), Sujin Song (Hannam University), Oh Yoen Kim (Dong-A University)

    • Obesity is no longer an individual or family problem but is recognized as a disease that society must solve together. It is also pointed out as a cause of socially enormous economic loss and class polarization. This session introduces community-based nutrition interventions and approaches for obesity management in vulnerable groups. The first speaker Dr. Shirley Y. Chao from the Massachusetts Executive Office of Elder Affairs in the USA will lecture on ‘Integrating Frailty and Malnutrition Screening into Community Care for Older Adults and Their Caregivers.' The second speaker Professor Seung Eun Jung from the University of Alabama in the USA will introduce 'Community-based Strategies to Decrease Health Disparities and Improve Nutritional Status for US Low-income Population.' Lastly, Professor Minsun Jeon of Chungnam National University in the Republic of Korea lectures on 'Nutrition Management Strategies for the Elderly and the Disabled in Social Welfare Facilities' and discusses obesity management in vulnerable groups in this session.
    • • References
      1. Chao S, Corish CA, Keller H, Rasmussen H, Arensberg MB, Dwyer JT.
      Are you prepared for the decade of healthy aging 2020-2030? A panel summary from the academy of nutrition and dietetics 2020 food & nutrition conference & expo virtual event, Nutrition Today 56(4):183-192, 2021.
      2. Jung SE, Shin YH, Kim H, Hermann J, Bice C. Identifying Underlying Beliefs About Fruit and Vegetable Consumption Among Low-Income Older Adults: An Elicitation Study Based on the Theory of Planned Behavior, J Nutr Educ Behav. 49(9):717-723, 2017
      3. Han S, Jeon M Development and Application of Nutrition Education Program for the Elderly in Low Income Korean Journal of Human Ecology. 28(2):171-183, 2019.
    09:20-09:45 Functional Supplements: Their Fat Controls and Molecular Mechanisms

    Yuri Kim

    (Ewha Womans University, Korea)
    09:45-10:10 Optimal Diets for Body Weight Management

    Yang Hu

    (Harvard T.H. Chan School of Public Health, USA)
    10:10-10:35 Trends in Diet Quality and Cardiometabolic Risk Factors Among Korean Adults

    Hannah Oh

    (Korea University, Korea)
    10:35-10:50 Panel Discussion

    SuJin Song

    (Hannam University, Korea),

    Hyun Ju You

    (Seoul National University, Korea)
  • 10:50-11:00

    Break

  • 11:00-11:40

    Presidential Lecture

    Chairperson : Kwang-Won Kim (Gachon University, Korea)

    Organizer: Soo Lim (Seoul National University, Republic of Korea), Jun Hwa Hong (Eulji University, Republic of Korea)

    • The interplay between adipose tissue's function as an energy reservoir and an endocrine organ is crucial for maintaining metabolic health. A key player in this dynamic balance is leptin, a hormone whose regulation is tightly linked to fat mass. Here we will discuss the multifaceted role of LATS1/2-YAP/TAZ signaling in regulating adipocyte plasticity and leptin production to maintain metabolic homeostasis.
    • • References
      1. Sethi, J.K. and A.J. Vidal-Puig, Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res, 2007. 48(6): p. 1253-62.
      2. Halder, G. and R.L. Johnson, Hippo signaling: growth control and beyond. Development, 2011. 138(1): p. 9-22.
    11:00-11:30 Obesity and Fatty Liver: Common but Ignored

    Cheol-Young Park

    (Sungkyunkwan University, Korea)
    11:30-11:40 Q&A

  • 11:40-11:50

    Break

  • 11:50-12:50

    Luncheon Symposium 7

    will be updated.
    11:50-12:50 SGLT2i: Beyond Glucose Lowering Effects

    Yong-Ho Lee

    (Yonsei University, Korea)
  • 12:50-13:30

    Special Scientific Session 2

    Organizer: Soo Lim (Seoul National University, Republic of Korea)

    • Matthias Blüher is Head of the Obesity Outpatient Clinic for Adults at the University of Leipzig Department of Medicine in Leipzig, Germany. He is Professor of Molecular Endocrinology, with board certifications in Internal Medicine, Endocrinology and Diabetology. From 2006 to 2012, Professor Blüher served as Head of the Clinical Research Group ‘Atherobesity,’ and since 2013, he has been Speaker of the Collaborative Research Center on obesity mechanisms.
    • Professor Blüher has won several awards, including the Obesity Research Award of the German Society for the Study of Obesity, the Ferdinand-Bertram-Prize of the German Diabetes Association, and the Rising Star Lecture at the 44th European Association for the Study of Diabetes (EASD) meeting. More recently, he received the Hans Christian Hagedorn Award from the German Diabetes Association in 2011 and the Minkowski Award from the EASD in 2015.
    • • References
      1. Blüher M, Aras M, Aronne LJ, Batterham RL, Giorgino F, Ji L, Pietiläinen KH, Schnell O, Tonchevska E, Wilding JPH. New insights into the treatment of obesity. Diabetes Obes Metab. 2023 Apr 13. doi: 10.1111/dom.15077.
      2. Blüher M. Metabolically Healthy Obesity. Endocr Rev. 2020 May 1;41(3):bnaa004.
    12:50-13:20 Clinical Implication of GLP-1 Receptor Agonists and SGLT2 Inhibitors from a Cardiometabolic Perspective

    Soo Lim

    (Seoul National University, Korea)
    13:20-13:30 Q&A
  • 13:50-14:30

    Plenary Lecture 3

    Chairperson : Kwan Woo Lee (Ajou University, Korea)

    Organizer: Il-Young Kim (Gachon University School of Medicine, Korea)

    • Prof. William Evans is widely respected as the world’s foremost authority in human muscle aging research. He was the first to describe the condition called sarcopenia, the age-related loss of muscle mass and strength. Muscle plays a central role in physiological metabolism beyond its role in physical function and various clinical conditions such as cancer, diabetes, insulin resistance, and obesity. Particularly in the context of weight management, muscle plays a key role in energy metabolism as loss of muscle mass with advancing age results in a substantial decrease in basal metabolic rate. In this keynote lecture, Prof. Evans will discuss the importance of muscle mass and metabolism on energy metabolism and functional capacity. Furthermore, Prof. Evans will introduce new methods for the evaluation of muscle mass that now enable demonstration of the importance of muscle mass and its association with poor functional status, risk of disability, hip fracture, and mortality.
    • • References
      1. Evans WJ, Cawthon PM. D(3)Creatine Dilution as a Direct, Non-invasive and Accurate Measurement of Muscle Mass for Aging Research. Calcif Tissue Int. 2023
      2. Cawthon PM, Blackwell T, Cummings SR, et al. Muscle mass assessed by D3-Creatine dilution method and incident self-reported disability and mortality in a prospective observational study of community dwelling ol0der men. J Gerontol A Biol Sci Med Sci. 2020
      3. Orwoll ES, Peters KE, Hellerstein M, Cummings SR, Evans WJ, Cawthon PM. The Importance of Muscle Versus Fat Mass in Sarcopenic Obesity: A Re-evaluation Using D3-Creatine Muscle Mass Versus DXA Lean Mass Measurements. J Gerontol A Biol Sci Med Sci. 2020
    13:50-14:20 How Muscle Mass and Metabolism Affects Energy Metabolism and Functional Capacity

    William Evans

    (University of California, Berkeley, USA)
    14:20-14:30 Q&A
  • 14:30-15:10

    Keynote Lecture 3

    Chairperson : Moon-Kyu Lee (Eulji University, Korea)

    Organizer: Soo Lim (Seoul National University, Republic of Korea)

    • Obesity is not only a serious disease in itself, but also a health risk factor that causes various diseases, so governmental plan and policy cooperation are needed. Korean government established and announced the first national obesity management comprehensive plan in 2018 to provide an opportunity to raise public awareness of the importance of obesity prevention and management and to monitor the pregress. In this lecture, I would like to introduce the past, present and future of Korea's national obesity strategy.
    14:30-15:00 Human Adipose Tissue Metabolism: What Happens with Obesity

    Michael D. Jensen

    (Mayo College of Medicine,USA)
    15:00-15:10 Q&A
  • 15:10-15:20

    Break

  • 15:20-16:50

    Symposium 19 : Expanding Horizons in Pediatric Obesity

    Chairpersons : Sochung Chung (Konkuk University, Korea) ,
    Junga Lee (Kyung Hee University, Korea)

    Organizer : Jaehyun Kim (Seoul National University, Korea), Yong Hee Hong (Soonchunhyang University, Korea)

    • In childhood and adolescent obesity, individual and family factors, lifestyle habits, as well as the given environment and school play an important role. This session will examine the status, necessity, and effectiveness of physical activity in schools, and explore strategies for managing obesity in children and adolescents in terms of social work, such as vulnerable groups and health inequalities. Lastly, in a situation where exposure to various social media is rapidly increasing in Korea, we will examine obesity management and education using social media that was studied among American college students, and examine its effectiveness and applicability. It is hoped that this session will provide an expanded perspective and insight into childhood and adolescent obesity.
    • • References
      1. Exploring Service Use Disparities among Suicidal Black Youth in a Suicide Prevention Care Coordination Intervention. J Racial Ethn Health Disparities. 2023;10(5):2231-2243
      2. Examining the effectiveness of a family-focused training to prevent youth suicide. Family Relations, 2023;72(1), 325–346
      3. Examining College Students’ Willingness to Consume Local Foods Utilizing the Health Belief Model with the Addition of Social Influence and Self-identity. Journal of Hunger and Environmental Nutrition. 2023;18(5): 736-752
      4. A Multi Theory-Based Investigation of College Students' Underlying Beliefs About Local Food Consumption. J Nutr Educ Behav. 2020 Oct;52(10):907-917
    15:20-15:45 The Effects of Physical Activity on Obesity and Health in Adolescents

    Jihyun Ahn

    (Kyeongin High School, Korea)
    15:45-16:10 Understanding Pediatric Obesity from a Social Work Perspective

    Eunji Nam

    (Incheon National University, Korea)
    16:10-16:35 The Effectiveness of Social Media Nutrition Education for Promoting Locally Grown Fruit and Vegetable Consumption Among College Students

    Seung Eun Jung

    (The University of Alabama, USA)
    16:35-16:50 Panel Discussion

    Jisun Park

    (Inha University, Korea)

    Kyoung Huh

    (Kium Pediatric Hospital, Korea)
  • 16:50-17:00

    Break

  • 17:00-17:40

    Plenary Lecture 4

    Chairperson : Kyu Rae Lee (Gachon University, Korea)

    will be updated.
    17:00-17:30 Semaglutide, a Second-Generation Obesity Medication for the Treatment and Prevention of Cardiometabolic Disease

    W. Timothy Garvey

    (University of Alabama at Birmingham, USA)
    17:30-17:40 Q&A
  • 17:40-18:00

    Closing & Award Ceremony

  • 09:20-10:50

    Symposium 16 : International Collaboration 2

    Chairpersons : Eun-Jung Rhee (Sungkyunkwan University, Korea) ,
    Chang Hee Jung (University of Ulsan, Korea)

    will be updated.
    09:20-09:45

    Dror Dicker

    (Tel Aviv University, Israel)
    09:45-10:10 GLP1+Glucagon Dual Agonist

    Erika Bezerra Parente

    (Boehringer Ingelheim, Germany)
    10:10-10:35

    W. Timothy Garvey

    (University of Alabama at Birmingham, USA)
    10:35-10:50 Panel Discussion
  • 12:50-13:50

    Oral Presentation 3

    Chairpersons : Bo Kyung Koo (Seoul National University, Korea),
    Jun Sung Moon (Yeungnam University, Korea)

    will be updated.
    12:50-13:00

    13:00-13:10

    13:10-13:20

    13:20-13:30

    13:30-13:40

  • 15:20-16:50

    Symposium 20 : Exercise and Cardiometabolic Dysfunction

    Chairpersons : Jong-Hee Kim (Hanyang University, Korea) ,
    Sewon Lee (Incheon National University, Korea)

    will be updated.
    15:20-15:45 Impact of Progressive Dynamic Resistance Training on Skeletal Muscle and Vascular Function in Older Adults

    Oh Sung Kwon

    (University of Connecticut, USA)
    15:45-16:10 Sleep, Metabolic Diseases, and the Role of Physical Activity in Middle and Older Individuals

    Jaehoon Seol

    (University of Tsukuba, Japan)
    16:10-16:35 Exercise Recommendation Algorithm for Improving Functional Movement: Focusing on Individuals with Obesity

    Min-Hwa Suk

    (Hanyang University, Korea)
    16:35-16:50 Panel Discussion

    Kyeongho Byun

    (Incheon National University, Korea),

    Seungyong Lee

    (Incheon National University, Korea)
  • 09:20-10:50

    Sponsored Session 3 : Optimization of Glycemic Control in Obese Diabetes Patients With CGM

    Chairpersons : Young Sung Suh (Keimyung University, Korea) ,
    Kyoung Kon Kim (Gachon University, Korea)

    will be updated.
    09:20-09:50

    Jun Sung Moon

    (Yeungnam University, Korea)
    09:50-10:20 Life Style Modification with CGM, How To Do?

    Sun-Joon Moon

    (Sungkyunkwan University, Korea)
    10:20-10:50 The Expanding Role of CGM in Wellness: From Glycemic Control to Holistic Health

    Jae Hyun Bae

    (Korea University, Korea)
  • 12:50-13:50

    Oral Presentation 4

    Chairpersons : Oh Yoen Kim (Dong-A University, Korea) ,
    Bo-Yeon Kim (Soonchunhyang University, Korea)

    will be updated.
    12:50-13:00

    13:00-13:10

    13:10-13:20

    13:20-13:30

    13:30-13:40

  • 15:20-16:50

    Joint Symposium KSSO-TOS : Real Word Experience of Anti-Obesity Medications

    Chairpersons : Marc-Andre Cornier (Medical University of South Carolina, USA),
    Soo Lim (Seoul National University, Korea)

    will be updated.
    15:20-15:50 Real-World Experience with Novel Anti-Obesity Medications

    Marc-Andre Cornier

    (Medical University of South Carolina, USA)
    15:50-16:20 GLP1 Receptor Agonists from Asian Perspective

    Yumi Kang

    (Harvard Medical School, USA)
    16:20-16:50 Real World Mental Health Implications of Anti-Obesity Medication Use

    Robyn Pashby

    (Health Psychology Partners, USA)
  • 12:50-13:25

    Guided Poster Presentation 2

    Chairpersons : Kyung-Soo Kim (CHA University, Korea)

    will be updated.
    12:50-12:57

    12:57-13:04

    13:04-13:11

    13:11-13:18

    13:18-13:25